Acurx Pharmaceuticals, Inc. Share Price
ACXPAcurx Pharmaceuticals, Inc. Stock Performance
Open $1.83 | Prev. Close $1.88 | Circuit Range N/A |
Day Range $1.80 - $1.83 | Year Range $1.37 - $21.00 | Volume 400 |
Average Traded $1.81 |
Acurx Pharmaceuticals, Inc. Share Price Chart
About Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
Acurx Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-May-26 | $1.83 | $1.88 | +0.00% |
20-May-26 | $1.83 | $1.88 | +5.03% |
18-May-26 | $1.85 | $1.79 | -8.21% |
15-May-26 | $1.89 | $1.95 | +1.04% |
14-May-26 | $1.88 | $1.93 | -1.03% |
13-May-26 | $1.96 | $1.95 | -4.18% |
12-May-26 | $1.88 | $2.04 | -5.79% |